CAROL VALDEZ: Open Payments
NPI 1376948547 · MISHAWAKA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,001 in 55 payments from 19 companies in 2025. Trend: 2023 $1,184 · 2024 $1,013 · 2025 $1,001
Food & beverage: $1,001
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $237 |
| ABBVIE INC. | 5 | $88 |
| GlaxoSmithKline, LLC. | 5 | $77 |
| Novo Nordisk Inc | 3 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Axsome Therapeutics, Inc. | 2 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| Lilly USA, LLC | 3 | $49 |
| Exact Sciences Corporation | 3 | $47 |
Products named: NURTEC ODT, REXULTI, VRAYLAR, JARDIANCE, Kerendia, Auvelity, TRELEGY ELLIPTA, Cologuard Collection Kit.
Industry payments across IN — which companies pay providers there.
